Department of Child Neurology and Metabolic Disorders, University Children's Hospital, Heidelberg, Germany.
Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
J Inherit Metab Dis. 2021 Jul;44(4):1070-1082. doi: 10.1002/jimd.12360. Epub 2021 Jan 28.
Inherited monoamine neurotransmitter disorders (iMNDs) are rare disorders with clinical manifestations ranging from mild infantile hypotonia, movement disorders to early infantile severe encephalopathy. Neuroimaging has been reported as non-specific. We systematically analyzed brain MRIs in order to characterize and better understand neuroimaging changes and to re-evaluate the diagnostic role of brain MRI in iMNDs. 81 MRIs of 70 patients (0.1-52.9 years, 39 patients with tetrahydrobiopterin deficiencies, 31 with primary disorders of monoamine metabolism) were retrospectively analyzed and clinical records reviewed. 33/70 patients had MRI changes, most commonly atrophy (n = 24). Eight patients, six with dihydropteridine reductase deficiency (DHPR), had a common pattern of bilateral parieto-occipital and to a lesser extent frontal and/or cerebellar changes in arterial watershed zones. Two patients imaged after acute severe encephalopathy had signs of profound hypoxic-ischemic injury and a combination of deep gray matter and watershed injury (aromatic l-amino acid decarboxylase (AADCD), tyrosine hydroxylase deficiency (THD)). Four patients had myelination delay (AADCD; THD); two had changes characteristic of post-infantile onset neuronal disease (AADCD, monoamine oxidase A deficiency), and nine T2-hyperintensity of central tegmental tracts. iMNDs are associated with MRI patterns consistent with chronic effects of a neuronal disorder and signs of repetitive injury to cerebral and cerebellar watershed areas, in particular in DHPRD. These will be helpful in the (neuroradiological) differential diagnosis of children with unknown disorders and monitoring of iMNDs. We hypothesize that deficiency of catecholamines and/or tetrahydrobiopterin increase the incidence of and the CNS susceptibility to vascular dysfunction.
遗传性单胺神经递质疾病(iMNDs)是罕见疾病,临床表现从婴儿期轻度肌无力、运动障碍到早发性婴儿严重脑病不等。神经影像学表现是非特异性的。我们系统地分析了脑 MRI,以描述和更好地理解神经影像学变化,并重新评估脑 MRI 在 iMNDs 中的诊断作用。回顾性分析了 70 例患者(0.1-52.9 岁,39 例四氢生物蝶呤缺乏症,31 例单胺代谢原发性疾病)的 81 份 MRI,同时回顾了临床记录。70 例患者中有 33 例出现 MRI 改变,最常见的是萎缩(n=24)。8 例患者,6 例二氢喋呤还原酶缺乏症(DHPR)患者,具有双侧顶枕部和程度较轻的额部和/或小脑动脉分水岭区域改变的常见模式。2 例在急性严重脑病后进行影像学检查的患者表现出严重缺氧缺血性损伤的迹象,以及深部灰质和分水岭损伤的组合(芳香族 L-氨基酸脱羧酶(AADCD)、酪氨酸羟化酶缺乏症(THD))。4 例患者出现髓鞘形成延迟(AADCD;THD);2 例患者出现符合婴儿后期神经元疾病的改变(AADCD、单胺氧化酶 A 缺乏症),9 例中央被盖束 T2 高信号。iMNDs 与 MRI 模式相关,这些模式与神经元疾病的慢性影响一致,以及大脑和小脑分水岭区域反复损伤的迹象,特别是在 DHPRD 中。这些将有助于(神经影像学)鉴别诊断原因不明的儿童,并监测 iMNDs。我们假设儿茶酚胺和/或四氢生物蝶呤的缺乏增加了血管功能障碍的发生和中枢神经系统的易感性。